NO20060425L - Ny imidazopyridinforbindelse II med terapeutisk effekt - Google Patents

Ny imidazopyridinforbindelse II med terapeutisk effekt

Info

Publication number
NO20060425L
NO20060425L NO20060425A NO20060425A NO20060425L NO 20060425 L NO20060425 L NO 20060425L NO 20060425 A NO20060425 A NO 20060425A NO 20060425 A NO20060425 A NO 20060425A NO 20060425 L NO20060425 L NO 20060425L
Authority
NO
Norway
Prior art keywords
therapeutic effect
imidazopyridine compound
new imidazopyridine
new
gastric acid
Prior art date
Application number
NO20060425A
Other languages
English (en)
Inventor
Peter Nordberg
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20060425L publication Critical patent/NO20060425L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Den foreliggende oppfinnelsen vedrører imidazo pyridinderivater med formel I som hemmer eksogen eller endogenstimulert magesyresekresjon og således kan anvendes ved forebyggelse og behandling av magesyrerelaterte sykdommer eller gastrointestinale inflammatoriske sykdommer.
NO20060425A 2003-06-26 2006-01-26 Ny imidazopyridinforbindelse II med terapeutisk effekt NO20060425L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0301904A SE0301904D0 (sv) 2003-06-26 2003-06-26 Novel imidazopyridine compound II with therapeutic effect
PCT/SE2004/001013 WO2004113339A1 (en) 2003-06-26 2004-06-23 Novel imidazopyridine compound ii with therapeutic effect

Publications (1)

Publication Number Publication Date
NO20060425L true NO20060425L (no) 2006-03-24

Family

ID=27656637

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060425A NO20060425L (no) 2003-06-26 2006-01-26 Ny imidazopyridinforbindelse II med terapeutisk effekt

Country Status (29)

Country Link
US (1) US7691875B2 (no)
EP (1) EP1641793B1 (no)
JP (1) JP4701168B2 (no)
KR (1) KR20060030479A (no)
CN (2) CN101941968A (no)
AR (1) AR044855A1 (no)
AT (1) ATE386033T1 (no)
AU (1) AU2004249655B2 (no)
BR (1) BRPI0411728A (no)
CA (1) CA2530181A1 (no)
DE (1) DE602004011773T2 (no)
DK (1) DK1641793T3 (no)
ES (1) ES2300796T3 (no)
HK (1) HK1088315A1 (no)
HR (1) HRP20080179T3 (no)
IL (1) IL172530A0 (no)
IS (1) IS8258A (no)
MX (1) MXPA05013643A (no)
MY (1) MY140718A (no)
NO (1) NO20060425L (no)
PL (1) PL1641793T3 (no)
PT (1) PT1641793E (no)
RU (1) RU2348634C2 (no)
SE (1) SE0301904D0 (no)
TW (1) TW200503702A (no)
UA (1) UA81953C2 (no)
UY (1) UY28384A1 (no)
WO (1) WO2004113339A1 (no)
ZA (1) ZA200510455B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010513561A (ja) * 2006-12-19 2010-04-30 ジェネンテック, インコーポレイテッド Iapのイミダゾピリジンインヒビター
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
SE9801526D0 (sv) 1998-04-29 1998-04-29 Astra Ab New compounds
SE9802794D0 (sv) 1998-08-21 1998-08-21 Astra Ab New compounds
KR20040058103A (ko) 2001-02-13 2004-07-03 아스트라제네카 아베 신규 개질 방출 제제
SE0102808D0 (sv) 2001-08-22 2001-08-22 Astrazeneca Ab New compounds

Also Published As

Publication number Publication date
ES2300796T3 (es) 2008-06-16
DE602004011773D1 (de) 2008-03-27
ZA200510455B (en) 2007-01-31
AR044855A1 (es) 2005-10-05
HK1088315A1 (en) 2006-11-03
EP1641793B1 (en) 2008-02-13
CN101941968A (zh) 2011-01-12
HRP20080179T3 (en) 2008-05-31
KR20060030479A (ko) 2006-04-10
US7691875B2 (en) 2010-04-06
RU2005141059A (ru) 2006-08-10
CA2530181A1 (en) 2004-12-29
PT1641793E (pt) 2008-04-17
RU2348634C2 (ru) 2009-03-10
MXPA05013643A (es) 2006-02-24
BRPI0411728A (pt) 2006-08-08
UA81953C2 (uk) 2008-02-25
SE0301904D0 (sv) 2003-06-26
PL1641793T3 (pl) 2008-07-31
UY28384A1 (es) 2005-01-31
JP4701168B2 (ja) 2011-06-15
DK1641793T3 (da) 2008-05-26
EP1641793A1 (en) 2006-04-05
US20070066642A1 (en) 2007-03-22
ATE386033T1 (de) 2008-03-15
DE602004011773T2 (de) 2009-02-05
AU2004249655A1 (en) 2004-12-29
CN1809567A (zh) 2006-07-26
JP2007521266A (ja) 2007-08-02
IL172530A0 (en) 2006-04-10
TW200503702A (en) 2005-02-01
AU2004249655B2 (en) 2008-04-17
MY140718A (en) 2010-01-15
WO2004113339A1 (en) 2004-12-29
IS8258A (is) 2006-01-23

Similar Documents

Publication Publication Date Title
SE9801526D0 (sv) New compounds
SE9700661D0 (sv) New compounds
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
NO20064120L (no) 3-'4-heterocyklyl-1,2,3,-triazol-l-yll-N-aryl-benzamid er som inhibitorer av cytokinproduksjon for behandling av kroniske inflammatoriske sykdommer
NO20053792L (no) Heterocykly-3-sulfonylindazoler som 5-hydroksytryptamin-6 ligander
CY1114038T1 (el) Παραγωγα ιμιδαζοπυριδινης τα οποια αναστελλουν την εκκριση γαστρικου οξεος
NO20052796L (no) Indolylpyrazinonderivater anvendelige for behandling av hyper-proliferative forstyrrelser og sykdommer assosiert med angiogenese
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
NO20064732L (no) Alfa-aminoamidderivater nyttige i behandlingen av urolige bein-syndromet og additive lidelser
NO20071534L (no) Behandling av inflammatoriske forstyrrelser og smerte
ECSP055844A (es) Nuevos compuestos triciclicos
MXPA04001402A (es) Compuestos de imidazopiridina novedosos con efecto terapeutico.
NO20010860L (no) Nye forbindelser
SE9602286D0 (sv) New compounds
SE9401197D0 (sv) Active compounds
NO20064632L (no) Tricykliske imidazopyridiner
NO20010861L (no) Nye forbindelser
NO20051040L (no) Anvendelse av alkylfosfokoliner i kombinasjon med antitumormedikamenter
NO20060425L (no) Ny imidazopyridinforbindelse II med terapeutisk effekt
SE0301905D0 (sv) Novel imidazopyridine compound I with therapeutic effect
SE0301903D0 (sv) Novel imidazopyridine compound III with therapeutic effect
ES2150494T3 (es) Derivados sustituidos de quinolina y su utilizacion como inhibidores de la secrecion de acido gastrico.
AR044854A1 (es) Compuesto de imidazopiridina
NO20072340L (no) Difluorsubstituerte Imidazopyridiner

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application